ENDRA Life Sciences Shares Soar After Launch of Postmarket Trial for TAEUS Liver System

MT Newswires Live10-23

ENDRA Life Sciences (NDRA) shares more than doubled Tuesday after the company said a post market clinical study was started at the LMU University Hospital in Munich, Germany to assess the liver fat measurement capabilities of its TAEUS system.

The company said a first patient was scanned with the TAEUS system in the study, which is designed to assess the system's utility for managing metabolic disease.

ENDRA said it expects the collaboration with LMU researchers to augment clinical data and support the company's de novo submission to the US Food and Drug Administration by mid-2025.

Price: 0.49, Change: +0.27, Percent Change: +124.43

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2477041363?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-23 01:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477041363","market":"nz","top_or_hot":-1,"title":"ENDRA Life Sciences Shares Soar After Launch of Postmarket Trial for TAEUS Liver System","media":"MT Newswires Live","content":"<html><body><p> ENDRA Life Sciences (NDRA) shares more than doubled Tuesday after the company said a post market clinical study was started at the LMU University Hospital in Munich, Germany to assess the liver fat measurement capabilities of its TAEUS system.</p><p>The company said a first patient was scanned with the TAEUS system in the study, which is designed to assess the system's utility for managing metabolic disease.</p><p>ENDRA said it expects the collaboration with LMU researchers to augment clinical data and support the company's de novo submission to the US Food and Drug Administration by mid-2025.</p><p>Price: 0.49, Change: +0.27, Percent Change: +124.43</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ENDRA Life Sciences Shares Soar After Launch of Postmarket Trial for TAEUS Liver System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nENDRA Life Sciences Shares Soar After Launch of Postmarket Trial for TAEUS Liver System\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-23 01:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ENDRA Life Sciences (NDRA) shares more than doubled Tuesday after the company said a post market clinical study was started at the LMU University Hospital in Munich, Germany to assess the liver fat ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2477041363","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2477041363","pubTimestamp":1729617827,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"ENDRA Life Sciences  shares more than doubled Tuesday after the company said a post market clinical study was started at the LMU University Hospital in Munich, Germany to assess the liver fat measurement capabilities of its TAEUS system.The company said a first patient was scanned with the TAEUS system in the study, which is designed to assess the system's utility for managing metabolic disease.ENDRA said it expects the collaboration with LMU researchers to augment clinical data and support the company's de novo submission to the US Food and Drug Administration by mid-2025.Price: 0.49, Change: +0.27, Percent Change: +124.43","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","NDRA":"ENDRA Life Sciences Inc"},"translate_title":"ENDRA Life Sciences启动TAEUS肝脏系统上市后试验后股价飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDRA":0.9},"content_text":"ENDRA Life Sciences (NDRA) shares more than doubled Tuesday after the company said a post market clinical study was started at the LMU University Hospital in Munich, Germany to assess the liver fat measurement capabilities of its TAEUS system.The company said a first patient was scanned with the TAEUS system in the study, which is designed to assess the system's utility for managing metabolic disease.ENDRA said it expects the collaboration with LMU researchers to augment clinical data and support the company's de novo submission to the US Food and Drug Administration by mid-2025.Price: 0.49, Change: +0.27, Percent Change: +124.43","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477041363"}